Communiqués Beta Bionics, Inc.

Actions

BBNX

US08659B1026

Equipement et technologie médicale avancés

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 10/08/2026			Varia. 5j.	Varia. 1 janv.
16,40 ^USD	+3,14%		+22,85%	-46,18%

29/07	Transcript : Beta Bionics, Inc., Q2 2026 Earnings Call, Jul 29, 2026
29/07	Beta Bionics, Inc. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI

Communiqués

29/07	Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 Guidance	GL
01/07	Beta Bionics to Announce Second Quarter 2026 Financial Results on July 29, 2026	GL
09/06	Beta Bionics (BBNX) Securities Investigation: Johnson Fistel Reviews Investor Losses Following Slower New Patient Start Growth	NE
03/06	Beta Bionics Investors Suffer Significant Losses After Company Reports Slower New Patient Start Growth; Contact Johnson Fistel	BU
02/06	Beta Bionics Investors Who Suffered Losses May Be Eligible for Recovery-Learn More Today, Contact Johnson Fistel	NE
02/06	Beta Bionics First in Automated Insulin Delivery to Publish Near Real-Time Real-World Data on a Public Website	GL
02/06	Beta Bionics First in Automated Insulin Delivery to Publish Near Real-Time Real-World Data on a Public Website	AQ
02/06	Robbins LLP is Investigating Allegations that the Officers and Directors of Beta Bionics, Inc. (BBNX) Violated Securities Laws and Breached Fiduciary Duties to Shareholders	BU
21/05	Beta Bionics Updates Commercialization Timeline Expectations for Mint™, its Patch Pump in Development	GL
21/05	Beta Bionics Updates Commercialization Timeline Expectations for Mint™, its Patch Pump in Development	AQ
27/04	Beta Bionics to Present at the Bank of America Securities Health Care Conference	GL
21/04	Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance	GL
31/03	Beta Bionics Introduces Bionic Insights™ in Bionic Reports — Transforming How Clinicians Understand and Optimize Diabetes Care	GL
30/03	Beta Bionics to Announce First Quarter 2026 Financial Results on April 21, 2026	GL
28/03	BBNX SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics	PR
26/03	BBNX SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics	NE
20/03	Faruqi & Faruqi, LLP Continues Investigation of Potential Securities Claims Against Bionics (BBNX)	NE
17/03	SHAREHOLDER INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Continues Investigation of Potential Securities Claims Against Bionics (NASDAQ: BBNX)	PR
12/03	INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics	PR
09/03	INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics	NE
05/03	INVESTIGATION NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics	PR
28/02	BBNX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics	PR
24/02	BBNX INVESTIGATION ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics	NE
19/02	Beta Bionics to Present at the TD Cowen 46th Annual Health Care Conference	GL
18/02	INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics	NE